23 May 2013
Keywords: gsk/theravance, start, asthma, drug, trials, uk, major
Article | 14 January 2008
UK drug major GlaxoSmithKline and USA-based biopharmaceutical company
Theravance say they have initiated Phase IIb trials of the inhaled
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 January 2008
22 May 2013
© 2013 thepharmaletter.com